Roquefort Therapeutics (ROQ) Stock Chart & Stock Price History GBX 4.12 +0.17 (+4.30%) (As of 11:39 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider Trades Roquefort Therapeutics Stock Price Performance 5 Day Performance+3.78%1 Month Performance+9.57%3 Month Performance+0.98%6 Month Performance-7.42%Year-To-Date Performance-43.17%1 Year Performance-36.62% Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address “Trump Trades” You’ve Got to Make (Ad)These Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to pop now that Donald Trump has been re-electedClaim your copy before they move ROQ Stock Chart for Friday, November, 22, 2024 ROQ Chart by TradingView Roquefort Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024GBX 4GBX 3.82-4.63%GBX 4.20GBX 3.792.70 million shs£4.93 million11/20/2024GBX 3.96GBX 4+1.14%GBX 4GBX 3.701.25 million shs£5.17 million11/19/2024GBX 4.13GBX 3.96-4.12%GBX 4.10GBX 3.85295,928 shs£5.11 million11/18/2024GBX 3.97GBX 4.13+3.90%GBX 4.13GBX 3.70543,272 shs£5.33 million11/15/2024GBX 3.89GBX 3.97+2.06%GBX 3.97GBX 3.80451,944 shs£5.13 million11/14/2024GBX 4.03GBX 3.89-3.47%GBX 4.08GBX 3.831.28 million shs£5.02 million Get the Latest News and Ratings for ROQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024GBX 4.35GBX 4.03-7.36%GBX 4.35GBX 3.902.16 million shs£5.21 million11/12/2024GBX 4.20GBX 4.35+3.57%GBX 4.40GBX 4.131.43 million shs£5.62 million11/11/2024GBX 4.23GBX 4.20-0.62%GBX 4.58GBX 4.061.83 million shs£5.42 million11/08/2024GBX 4.60GBX 4.23-8.11%GBX 425GBX 4.156.45 million shs£5.46 million11/07/2024GBX 5.60GBX 4.60-17.88%GBX 5.20GBX 4.505.85 million shs£5.94 million11/06/2024GBX 5.60GBX 5.60GBX 5.60GBX 4.992.15 million shs£7.23 million11/05/2024GBX 6.50GBX 5.60-13.85%GBX 5.80GBX 5.405.72 million shs£7.23 million11/04/2024GBX 5.13GBX 6.50+26.76%GBX 6.50GBX 5.612.92 million shs£8.40 million11/01/2024GBX 5.55GBX 5.13-7.60%GBX 5.60GBX 4.805.78 million shs£6.62 million10/31/2024GBX 4.92GBX 5.55+12.85%GBX 6GBX 4.806.29 million shs£7.17 million10/30/2024GBX 4.25GBX 4.92+15.72%GBX 4.92GBX 4.261.58 million shs£6.35 million10/29/2024GBX 4.37GBX 4.25-2.79%GBX 4.40GBX 4.151.56 million shs£5.49 million10/28/2024GBX 3.95GBX 4.37+10.68%GBX 4.55GBX 3.952.15 million shs£5.65 million10/25/2024GBX 3.80GBX 4+5.18%GBX 4GBX 3.602.09 million shs£5.16 million10/24/2024GBX 3.50GBX 3.80+8.57%GBX 3.80GBX 3.50944,645 shs£4.91 million10/23/2024GBX 3.76GBX 3.50-6.91%GBX 3.85GBX 3.50303,513 shs£4.52 million10/22/2024GBX 3.70GBX 3.76+1.62%GBX 3.86GBX 3.70954,685 shs£4.86 million10/21/2024GBX 3.70GBX 3.70GBX 3.90GBX 3.55460,438 shs£4.78 million Related Companies NSCI Stock Price Chart OPTI Stock Price Chart ONC Stock Price Chart SNG Stock Price Chart BVX Stock Price Chart CIZ Stock Price Chart IMM Stock Price Chart GENF Stock Price Chart IXI Stock Price Chart APTA Stock Price Chart Receive ROQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:ROQ) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roquefort Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Roquefort Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
